title: Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE).
authors.affiliation: University Department of Growth and Reproduction, Rigshsopitalet, Copenhagen, Denmark. ajuul@dadlnet.dk
authors.forename: Anders
authors.initials: A
authors.lastname: Juul
authors.forename: Sergio
authors.initials: S
authors.lastname: Bernasconi
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Carel
authors.forename: Peter E
authors.initials: PE
authors.lastname: Clayton
authors.forename: Wieland
authors.initials: W
authors.lastname: Kiess
authors.forename: Sabine
authors.initials: S
authors.lastname: DeMuinck-Keizer Schrama
mesh_terms: D019382:Human Growth Hormone / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced*
chemical_list: D019382:Human Growth Hormone